Medtronic accepts terms of preliminary injunction

30 June 2009 00:00 in Medical Company Product News


Medtronic has accepted the terms of an order that mean a company will not be able to use misleading marketing claims related to its Kyphon Balloon Kyphoplasty.

On May 19th, the German competition court granted the company a preliminary injunction against DFine Europe.

As part of the order, the firm is to no longer use certain promotional claims that compare its bone StabiliT ER2 to Medtronic's KyphX HV-R Bone Cement.

DFine Europe has also agreed to the terms.

Under German law, a preliminary injunction is given as an action against anti-competitive behaviour, which includes illegal advertising.

Meanwhile, the Food and Drug administration has granted Physio-Control ? a wholly-owned subsidiary of Medtronic - marketing clearance for its next-generation Lucas Chest Compression.

The device is an automated item that gives consistent treatment to victims in cardiac arrest, without any interruptions.

President of Physio-Control Brian Webster said the product was in response to customers who had been asking for a battery-operated version of the Lucas over the last couple of years.

Other news stories from 30/06/2009

• UCB voices delight at Neupro availability
• Gilead pleased with CHMP recommendation
• Sanofi-Aventis says patient safety is important
• Hospira first to offer azithromycin drug delivery system
• Beiersdorf says it is pleased to launch new products
• Takeda submits extra Alogliptin applications
• Novo Nordisk discusses safety of insulin products
• Royal Canin welcomes new recruits
• Reckitt Benckiser competes during economic downturn
• Prostate cancer screening proven ineffective
• Bausch and Lomb launches information centre
• Inquest opens into girl's death from swine flu
• Calls for a tripling of dementia research funding
• Swine flu may have been leaked from laboratory
• Roche says it wants to think about ABPI relationship
• Covidien ranked number one innovator
• Medtronic accepts terms of preliminary injunction
• Bayer Schering Pharma to develop cancer-related targets
• AstraZeneca to pay milestone if Vimovo is approved
• Procter and Gamble advertisements feature sporting greats
• Church and Dwight says it is saddened by death of spokesperson
• Ceva Animal Health's product recommended to calm dogs
• Bayer Animal Health sponsors TV show
• The Body Shop comes top of recruitment site list
• Fort Dodge Animal Health says producers can have access to experts
• Public offered allergy screenings
• Pre-registration pharmacists to take part in pilot scheme
• Thermo Fisher Scientific solvent delivery systems said to bring flexibility
• Agilent Technologies says new oscilloscope probe positioners are stable and quick
• Mettler Toledo says balance range brings lasting value

Related news

• Medtronic receives CE Mark for new ReDuX Plier
• Medtronic reports positive findings from Endurant study
• Medtronic's CoreValve system approved in Europe for VIV procedures
• Medtronic reports positive financial data for Q4 2013
• Medtronic study shows benefits of new heart failure therapy

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Adfero News Agency

Feedback | News Archive | Browse News | Hotels | Links | Browse Jobs | Legal Notice | Privacy Policy

© Copyright 2013 Zenopa Ltd